Poster Presentation 27th Lorne Cancer Conference 2015

CHARACTERISATION OF A CHECKPOINT AND REPAIR RESPONSE TO UVB-EXPOSURE THAT IS COMMONLY DEFECTIVE IN MELANOMA (#145)

Mareike Dahmer-Heath 1 , Alex Pinder 1 , Nicole Cloonan 2 , Konstantin Shakhbazov 3 , Nichole Giles 4 , Andrew Burgees 5 , Dubravka Skalamera 1 , Max Ranall 1 , Michelle Hill 1 , Marcel Dinger 5 , Brian Gabrielli 1 , Sandra Pavey 1
  1. University of Queensland Diamantina Institute, Woolloongabba, QLD, Australia
  2. QIMR Berghofer Medical Research Institute, Herston, QLD, Australia
  3. University of Queensland, Queensland Brain Institute, St Lucia, QLD, Australia
  4. University of Queensland, Institute of Molecular Bioscience, St Lucia, QLD, Australia
  5. Garvan Institute, Darlinghurst, NSW, Australia

Background:

The high load of UV signature DNA mutations found in melanomas is evidence of not only the role of UV in melanomagenesis but also of a defect in repair of UV-induced lesions.  We have previously identified a G2 phase cell cycle checkpoint and repair response to low-dose UVB that is commonly defective in melanoma cell lines.  Here we aim to identify the components of the checkpoint and repair pathways involved in this UV-induced response. 

Methods:

We have investigated the global alterations in: transcription; translation; protein abundance; and microRNAs associated with the UV response. We have used two model systems previously characterised for the UV-induced G2 delay, an A2058 melanoma cell line model and a whole skin organ culture model. Total mRNA and polysome mRNA were analysed using Illumina whole genome microarrays, microRNAs were analysed by RNA-seq, and protein changes were analysed by SILAC proteomics.

Results:

Data was combined from these analyses to identify a set of 45 high probability candidates, and 11 UV-responsive mircroRNAs potentially contributing to this response. Candidates are being further examined using high-throughput functional analyses, to determine their involvement in the normal UV response. A summary of ongoing work characterising the UV response will be presented.

Conclusions:

Once the mechanisms of the normal UV response have been characterised, we can identify defects in the normal surveillance, checkpoint and/or repair mechanisms which allow escape of  UV-induced mutations.  This may offer opportunities to expand diagnostic (and potentially therapeutic) options for melanoma patients.